Cell culture experiments of LNCaP prostate cancer cells co-treated with dihydrotestosterone (DHT) and ARE-targeted polyamides have shown decreased expression of several AR-driven genes such as PSA, KLK2, and TMPRSS2 when compared to samples treated with DHT alone. Here, AR is linked to prostate cancer.